<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Changing definitions and classifications of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (HMs) complicate incidence comparisons </plain></SENT>
<SENT sid="1" pm="."><plain>HAEMACARE classified HMs into groupings consistent with the latest World Health Organization classification and useful for epidemiologic and public health purposes </plain></SENT>
<SENT sid="2" pm="."><plain>We present crude, age-specific and age-standardized incidence rates for European HMs according to these groupings, estimated from 66,371 lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (LMs) and 21,796 myeloid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (MMs) registered in 2000-2002 by 44 European <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries, grouped into 5 regions </plain></SENT>
<SENT sid="3" pm="."><plain>Age-standardized incidence rates were 24.5 (per 100,000) for LMs and 7.55 for MMs </plain></SENT>
<SENT sid="4" pm="."><plain>The commonest LMs were plasma cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (4.62), small B-cell lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:hpo ids='HP_0005550'>chronic lymphatic leukemia</z:hpo> (3.79), diffuse B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (3.13), and Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (2.41) </plain></SENT>
<SENT sid="5" pm="."><plain>The commonest MMs were <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (2.96), other myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (1.76), and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (1.24) </plain></SENT>
<SENT sid="6" pm="."><plain>Unknown <z:mp ids='MP_0000002'>morphology</z:mp> LMs were commonest in Northern Europe (7.53); unknown <z:mp ids='MP_0000002'>morphology</z:mp> MMs were commonest in Southern Europe (0.73) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall incidence was lowest in Eastern Europe and lower in women than in men </plain></SENT>
<SENT sid="8" pm="."><plain>For most LMs, incidence was highest in Southern Europe; for MMs incidence was highest in the United Kingdom and Ireland </plain></SENT>
<SENT sid="9" pm="."><plain>Differences in diagnostic and registration criteria are an important cause of incidence variation; however, different distribution of HM risk factors also contributes </plain></SENT>
<SENT sid="10" pm="."><plain>The quality of population-based HM data needs further improvement </plain></SENT>
</text></document>